Mercado de modelos de hígado humano: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00025128
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 178
Buy Now

Se prevé que el mercado de modelos de hígado humano alcance los 508,26 millones de dólares en 2028, desde los 233,90 millones de dólares de 2021; se espera que crezca a una tasa compuesta anual del 11,7% de 2021 a 2028.

El crecimiento del mercado se atribuye principalmente a la creciente prevalencia de enfermedades hepáticas y al creciente enfoque en desarrollar alternativas para modelos de experimentación con animales. Sin embargo, los altos costos de los modelos de hígado humano y los problemas con la incorporación de modelos de hígado en el flujo de trabajo existente están obstaculizando el crecimiento del mercado de modelos de hígado humano. El hígado es un órgano importante que realiza funciones vitales del cuerpo, como la síntesis de factores de coagulación sanguínea, la producción de bilis, la producción de proteínas y la desintoxicación. Se utilizan modelos de hígado humano para estudiar la toxicidad del fármaco y permitir comprender el efecto de los fármacos y la progresión de la enfermedad hepática. El creciente interés en el desarrollo de alternativas para los modelos de experimentación con animales es uno de los principales factores que se estima fomentará el crecimiento de los modelos mundiales de hígado humano en los próximos años.

Perspectivas estratégicas

La industria biofarmacéutica de Asia Pacífico se vio perturbada durante algunos meses de 2020 debido al brote de COVID-19. La pandemia de COVID-19 ha afectado los ensayos clínicos de manera incomparable debido a los múltiples niveles de restricciones impuestas para controlar la propagación de la infección. Sin embargo, con la creciente demanda de productos para tratar la infección por COVID-19, las empresas biofarmacéuticas y farmacéuticas de India y China han aumentado sus actividades de investigación, lo que está impactando positivamente el crecimiento del mercado.

 

regiones lucrativas para el mercado de modelos de hígado humano


Perspectivas del mercado

Creciente La prevalencia de enfermedades hepáticas impulsa el crecimiento del mercado de modelos de hígado humano

El hígado es el órgano interno más grande del cuerpo humano y realiza más de 500 funciones. La toxicidad hepática es una preocupación importante en la evaluación de riesgos, ya que el hígado está expuesto a la mayoría de los compuestos xenobióticos y sus metabolitos bioactivos, lo que lo hace susceptible a la enfermedad hepática inducida químicamente. El virus de la hepatitis C (VHC), el virus de la hepatitis B crónica (VHB), la enfermedad del hígado graso no alcohólico (NAFLD) y la enfermedad hepática asociada al alcohol (ALD) se encuentran entre las principales causas de enfermedad hepática crónica. La hepatitis viral sigue siendo la principal causa de muerte por insuficiencia hepática y, al mismo tiempo, la NAFLD se ha convertido en uno de los factores que contribuyen a la morbilidad hepática y la mortalidad asociada de más rápido crecimiento. Según las estadísticas nacionales del Reino Unido, las enfermedades hepáticas se han clasificado como la quinta causa de muerte en el país.

Además, estas enfermedades se consideran la segunda causa de muerte. principal causa de muerte entre todas las enfermedades digestivas en los EE. UU. Según la Asociación Estadounidense para el Estudio de Enfermedades Hepáticas, en 2017, la carga global de cáncer de hígado y cirrosis había aumentado. Los NAFLD tienen una prevalencia estimada de ~25% en la población general. Casi un tercio de la población estadounidense tiene NAFLD, y las personas con diabetes mellitus tipo 2 u obesidad se ven afectadas de manera desproporcionada; Se espera que el número de casos de NAFLD aumente de 83,1 millones de personas en 2015 a 100,9 millones en 2030. Por lo tanto, un aumento en la prevalencia global de enfermedades hepáticas, incluidas enfermedades crónicas y agudas e infecciones microbianas, aumenta la demanda de modelos hepáticos.

Información basada en tipos

Según el tipo, el mercado de modelos de hígado humano se segmenta aún más en organoides hepáticos, hígado en un chip , modelos 2D, bioimpresión 3D y otros. El segmento de organoides hepáticos tiene la mayor participación del mercado. Sin embargo, se prevé que el segmento de hígado en chip registre la CAGR más alta durante 2021-2028. Los avances en la tecnología de organoides hepáticos proporcionan modelos para el desarrollo prenatal, la preservación de tejidos y patologías, que impulsarían el crecimiento del mercado de este segmento en los próximos años.

Modelos de hígado humano Mercado, por tipo: 2021 y 2028


Información basada en aplicaciones

Basado en la aplicación, los modelos de hígado humano El mercado se segmenta aún más en educación, descubrimiento de fármacos y otros. El segmento de descubrimiento de fármacos posee la mayor participación del mercado de modelos de hígado humano; sin embargo, se anticipa que el segmento educativo registre la CAGR más alta durante el período de pronóstico.

Información basada en el usuario final

Según el usuario final, El mercado de modelos de hígado humano está segmentado en institutos de investigación, empresas farmacéuticas y de biotecnología, entre otros. El segmento de empresas farmacéuticas y biotecnológicas tiene la mayor cuota de mercado. Sin embargo, se estima que el segmento de institutos de investigación registrará la CAGR más alta durante el período de pronóstico. El crecimiento de mercado proyectado para este segmento se puede atribuir a un aumento en las colaboraciones entre la industria y las universidades para la investigación del genoma y los avances tecnológicos en la producción de modelos de hígado humano.

Las empresas que operan en el mercado de modelos de hígado humano están adoptando estrategias de innovación de productos para satisfacer las cambiantes demandas de los clientes en todo el mundo, lo que también les permite mantener su marca en el mercado global.

Mercado de modelos de hígado humano - ndash; por tipo

  • Organoides hepáticos
  • Hígado en un chip
  • Modelos 2D
  • Bioimpresión 3D
  • Otros

Mercado de modelos de hígado humano: ndash; por aplicación

  • Descubrimiento de fármacos
  • Educativo
  • Otro

Mercado de modelos de hígado humano: por Usuario Final

  • Empresas Farmacéuticas y Biotecnológicas
  • Institutos de Investigación
  • Otros

 

Mercado de modelos de hígado humano: por Geografía

  • América del Norte
    • Estados Unidos
    • Canadá
    • México
  • < li>Europa
    • Francia
    • Alemania
    • Italia
    • Reino Unido
    • España
    • Resto de Europa
  • Asia Pacífico (APAC)
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia
    • Resto de APAC
  • Medio Oriente y Asia África (MEA)
    • Sudáfrica
    • Arabia Saudita
    • EAU
    • Resto de MEA
  • América del Sur y Central (SCAM)
    • Brasil
    • Argentina
    • Resto de SCAM
  • Perfiles de empresas

    • THERMO FISHER SCIENTIFIC INC.
    • Emulate, Inc.
    • CN Bio Innovations,
    • CYFUSE BIOMEDICAL KK
    • MIMETAS BV
    • InSphero
    • BioIVT
    • CELLINK
    • Kerafast
    • Cyprio
    • Kirkstall
    • ORGANOVO HOLDINGS INC    
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the human liver models market across the globe?

The factors that are driving growth of the market are increasing prevalence of liver diseases, and growing focus on developing alternatives for animal testing models.

Who are the developments carrying out by major players in the human liver models market?

Various companies have made organic growth strategies in the human liver models market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as InSphero, Emulate, Inc amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.

Which region is dominated the human liver models market?

North America dominates the global human liver models market due to factors such as increasing incidences of the liver diseases such as cirrhosis, chronic liver disease (CLD), Nonalcoholic fatty liver disease (NAFLD) and others across the country. Moreover, the growth of market in Canada is expected to grow due to increasing support from the government to address the rising concerns about the liver diseases.

Which segment is growing at the highest CAGR in the human liver models market?

The liver-on-a-chip segment is growing at the highest CAGR owing to increasing demand for cost-effective alternatives to animal models for drug research and development.

Which region is the fastest growing in the human liver models market?

Asia Pacific is expected to be the fastest growing region in the Human Liver Models market. The growth of the market in this region is primarily due to growing biopharmaceutical industry, increasing number of clinical trials, and increasing research activities for the development of innovative therapies.

The List of Companies - Human Liver Models Market

  1. THERMO FISHER SCIENTIFIC INC.
  2. Emulate, Inc.
  3. CN Bio Innovations,
  4. CYFUSE BIOMEDICAL K.K.
  5. MIMETAS BV
  6. InSphero
  7. BioIVT
  8. CELLINK
  9. Kerafast
  10. Cyprio
  11. Kirkstall
  12. ORGANOVO HOLDINGS INC      

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports